Medtronic Received FDA Clearance for the New Inpen™ App, Paving the Way for its Smart MDI System Launch with Simplera™ CGM
On November 20, 2024, Medtronic, a global leader in healthcare technology, announced the U.S. Food and Drug Administration (FDA) clearance for its new InPen™ app, which includes advanced features such as missed meal dose detection. This milestone set the stage for the upcoming launch of Medtronic’s Smart MDI system, which integrates the InPen™ smart insulin pen with the Simplera™ continuous glucose monitor (CGM). The Simplera™ CGM represents a breakthrough as the company’s first disposable, all-in-one CGM, offering a compact design that i...